Financhill
Sell
27

COR Quote, Financials, Valuation and Earnings

Last price:
$337.59
Seasonality move :
6.28%
Day range:
$333.39 - $352.14
52-week range:
$223.92 - $377.54
Dividend yield:
0.67%
P/E ratio:
42.17x
P/S ratio:
0.20x
P/B ratio:
43.13x
Volume:
3.4M
Avg. volume:
1.6M
1-year change:
34.1%
Market cap:
$65B
Revenue:
$321.3B
EPS (TTM):
$7.95

Analysts' Opinion

  • Consensus Rating
    Cencora, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $384.79, Cencora, Inc. has an estimated upside of 14.76% from its current price of $335.31.
  • Price Target Downside
    According to analysts, the lowest downside price target is $300.00 representing 10.53% downside risk from its current price of $335.31.

Fair Value

  • According to the consensus of 14 analysts, Cencora, Inc. has 14.76% upside to fair value with a price target of $384.79 per share.

COR vs. S&P 500

  • Over the past 5 trading days, Cencora, Inc. has underperformed the S&P 500 by -10.53% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cencora, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cencora, Inc. has grown year-over-year revenues for 52 quarters straight. In the most recent quarter Cencora, Inc. reported revenues of $83.7B.

Earnings Growth

  • Cencora, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cencora, Inc. reported earnings per share of -$1.75.
Enterprise value:
70.2B
EV / Invested capital:
6.34x
Price / LTM sales:
0.20x
EV / EBIT:
19.25x
EV / Revenue:
0.22x
PEG ratio (5yr expected):
7.09x
EV / Free cash flow:
21.90x
Price / Operating cash flow:
20.37x
Enterprise value / EBITDA:
14.92x
Gross Profit (TTM):
$10.1B
Return On Assets:
2.19%
Net Income Margin (TTM):
0.49%
Return On Equity:
124.72%
Return On Invested Capital:
17.24%
Operating Margin:
1.02%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $262.2B $294B $321.3B $79.1B $83.7B
Gross Profit $7.8B $8.7B $10.1B $2.2B $2.6B
Operating Income $2.4B $3B $3.6B $672.9M $854.6M
EBITDA $3.4B $4.1B $4.7B $951M $1.1B
Diluted EPS $8.53 $7.51 $7.95 $0.02 -$1.75
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $38.8B $39.6B $42.8B $47.7B $52.2B
Total Assets $57.3B $56.6B $62.6B $67.1B $76.6B
Current Liabilities $41.4B $43.5B $48.8B $54.3B $57.8B
Total Liabilities $56.8B $56.5B $61.9B $66.3B $74.8B
Total Equity $584.4M $71.3M $666.3M $786.7M $1.7B
Total Debt $7.6B $5.7B $5.7B $5.4B $9.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $3.9B $3.5B $3.9B $1B $3.1B
Cash From Investing -$2.6B -$618.1M -$5B -$241.9M -$321.9M
Cash From Financing -$2.2B -$2.3B $2.2B -$957.3M -$683.8M
Free Cash Flow $3.5B $3B $3.2B $818.1M $2.9B
COR
Sector
Market Cap
$65B
$28.4M
Price % of 52-Week High
88.81%
50.35%
Dividend Yield
0.67%
0%
Shareholder Yield
-0.14%
-1.32%
1-Year Price Total Return
34.1%
-22.19%
Beta (5-Year)
0.632
0.521
Dividend yield:
0.67%
Annualized payout:
$2.20
Payout ratio:
15.62%
Growth streak:
20 years

Technicals

8-day SMA
Sell
Level $362.03
200-day SMA
Buy
Level $297.65
Bollinger Bands (100)
Buy
Level 287 - 342.92
Chaikin Money Flow
Buy
Level 470.3M
20-day SMA
Sell
Level $362.06
Relative Strength Index (RSI14)
Sell
Level 35.98
ADX Line
Sell
Level 36.73
Williams %R
Buy
Level -95.6512
50-day SMA
Sell
Level $337.44
MACD (12, 26)
Buy
Level 4.70
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 179.5M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.8706)
Sell
CA Score (Annual)
Level (-0.7035)
Buy
Beneish M-Score (Annual)
Level (-2.5377)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.8076)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Stock Forecast FAQ

In the current month, COR has received 10 Buy ratings 4 Hold ratings, and 0 Sell ratings. The COR average analyst price target in the past 3 months is $384.79.

  • Where Will Cencora, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cencora, Inc. share price will rise to $384.79 per share over the next 12 months.

  • What Do Analysts Say About Cencora, Inc.?

    Analysts are divided on their view about Cencora, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cencora, Inc. is a Sell and believe this share price will drop from its current level to $300.00.

  • What Is Cencora, Inc.'s Price Target?

    The price target for Cencora, Inc. over the next 1-year time period is forecast to be $384.79 according to 14 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is COR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cencora, Inc. is a Buy. 10 of 14 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of COR?

    You can purchase shares of Cencora, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cencora, Inc. shares.

  • What Is The Cencora, Inc. Share Price Today?

    Cencora, Inc. was last trading at $337.59 per share. This represents the most recent stock quote for Cencora, Inc.. Yesterday, Cencora, Inc. closed at $335.31 per share.

  • How To Buy Cencora, Inc. Stock Online?

    In order to purchase Cencora, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock